Lenalidomide is a highly effective treatment for myelodysplastic syndrome (MDS) with deletion of chromosome 5q (del(5q)). Here, we demonstrate that lenalidomide induces the ubiquitination of ...

Data are lacking on whether lenalidomide maintenance therapy prolongs the time to disease progression after autologous hematopoietic stem-cell transplantation in patients with multiple myeloma.

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data ...

Lenalidomide is a structural analogue of thalidomide with similar but more potent biologic activity. This phase 3, placebo-controlled trial investigated the efficacy of lenalidomide plus ...

Effect of CBM588 in combination with cabozantinib plus nivolumab for patients (pts) with metastatic renal cell carcinoma (mRCC): A randomized clinical trial. Primary overall survival analysis of the ...

Factors associated with dose adjustment for the bortezomib, lenalidomide, dexamethasone regimen among patients with newly diagnosed multiple myeloma. This is an ASCO Meeting Abstract from the 2022 ...

New treatments for multiple myeloma have greatly increased survival, and this longer life expectancy has led to renewed concern about the risk for secondary malignancies. There was no difference ...

May 10, 2012 — Lenalidomide (Revlimid) combined with dexamethasone has proven to be an effective treatment for patients with newly diagnosed or relapsed/refractory multiple myeloma. Three new ...

Joshua Richter, MD: We have a litany of studies showing that when you’re on a lenalidomide-based regimen up front, you ought to remain on it until progression or intolerance. There may be some ...

The Appraisal Committee reviewed the data available on the clinical and cost effectiveness of lenalidomide, having considered evidence on the nature of low‑ or intermediate‑1 risk myelodysplastic ...

The Appraisal Committee reviewed the data available on the clinical and cost effectiveness of lenalidomide, having considered evidence on the nature of multiple myeloma and the value placed on the ...